Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ligand Pharmaceuticals Inc.    LGND

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Ligand Pharmaceuticals Inc. : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/17/2013 | 06:55pm CET

NEW YORK, May 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ligand Pharmaceuticals Incorporated (NasdaqGM: LGND), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

To get more information, click here: http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/. There is no cost or obligation to you.

If you own common stock in Ligand Pharmaceuticals Incorporated and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


© PRNewswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LIGAND PHARMACEUTICALS INC
11/16 REMINDER : Ligand to Host Analyst Day on November 14th in New York City
11/16 LIGAND PHARMACEUTICALS : Provides Highlights from Today's Analyst Day Event
11/15 LIGAND PHARMACEUTICALS INCORPORATED : LGND) Files An 8-K Regulation FD Disclosu..
11/14 LIGAND PHARMACEUTICALS INC : Regulation FD Disclosure, Financial Statements and ..
11/14 LIGAND PHARMACEUTICALS : Provides Highlights from Today’s Analyst Day Even..
11/13 LIGAND PHARMACEUTICALS INCORPORATED : LGND) Files An 8-K Other Events
11/13 LIGAND PHARMACEUTICALS INC : Other Events (form 8-K)
11/09 LIGAND PHARMACEUTICALS : tops 3Q revenue forecasts
11/09 LIGAND PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condi..
11/09 LIGAND PHARMACEUTICALS INC : Results of Operations and Financial Condition (form..
More news
News from SeekingAlpha
11/29 YOUR DAILY PHARMA SCOOP : Omeros If And Buts, Egalet's Oxycodone Success, Auris ..
11/23 YOUR DAILY PHARMA SCOOP : Exelixis Still Attractive, Portola's BevyxXa, Pluriste..
11/20 Midday Gainers / Losers
11/20 Premarket analyst action - healthcare
11/16 YOUR DAILY PHARMA SCOOP : A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tu..